Loading organizations...

§ Venture Capital · Beijing, Beijing, China
Private equity fund investing in healthcare assets for China's healthcare industry, a China Life alternative investment.
China Life Healthcare Fund operates as a leading private equity fund dedicated to the healthcare sector within China. It strategically deploys capital into enterprises across life sciences, medical technology, healthcare services, and digital health, fostering innovation and development in critical areas of the industry. The fund's approach involves identifying high-potential ventures that align with its mandate to create value and advance healthcare solutions.
The fund was launched in November 2016 by China Life Private Equity Investment Co., Ltd., which itself was established in June 2016 as a professional investment platform and subsidiary of China Life. Its inception marked one of the first private equity funds sponsored by insurance capital to receive regulatory approval, signaling a strategic commitment from a major financial institution to invest in China's burgeoning healthcare landscape. This move was predicated on identifying significant opportunities for capital deployment and industry impact.
The fund primarily invests in companies developing advanced solutions within the aforementioned healthcare segments, supporting their growth and market penetration. Its overarching vision is to cultivate a first-class healthcare investment platform and service provider in China, thereby driving future innovation and generating substantial value within the nation’s healthcare ecosystem. The fund remains focused on long-term growth and strategic partnerships that contribute to a healthier future.
China Life Healthcare Fund has 1 tracked investment across 1 company. The latest tracked deal is $46.0M Series B Extension in XtalPi in October 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 24, 2018 | XtalPi | $46.0M Series B Extension | China Life Healthcare Fund | SIG |